Nivolumab Plus Stereotactic Body Radiotherapy in II and III Line of Patients With Metastatic Renal Cell Carcinoma
Clinical trial NCT03469713 · COMPLETED
Trial details
- NCT number
- NCT03469713
- Sponsor
- Gruppo Oncologico Italiano di Ricerca Clinica
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-14
- Primary completion
- 2019-03-04
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.